Vascular intervention robots move from 'feasibility' to 'benefit'
血管介入机器人从“可行”走向“获益”
A research series by Peking University First Hospital's Neurosurgery Department evaluates robot-assisted vascular interventions, finding that while they offer significant benefits in reducing operator radiation exposure and maintaining comparable safety to manual procedures, challenges in procedural efficiency and long-term outcomes remain. The study concludes that robots should currently serve as a selective supplement to manual intervention rather than a universal replacement, pending further high-quality comparative trials.
The study provides a systematic review and meta-analysis of robot-assisted vascular interventions, identifying reduced operator radiation exposure as the primary current benefit while noting that procedural efficiency remains an area for optimization.
Source: Chinese robotics — Research news discovery · Read original article ↗
English translation unavailable. Choose the original article to read it.
What the source reports
Publisher-reported claims, with original evidence. These results have not been independently verified by RoboSignal.
Reported numbers
randomized controlled trials included in analysis
3
Reported trials
total studies included in systematic review and meta-analysis
40
- paper: not_reported
Source excerpts and review record
Automatically extracted; no manual editorial approval recorded.
最终的系统综述与Meta分析共纳入40项研究，共有3870名患者接受机器人辅助血管介入，1142名接受传统人工血管介入。
Open source S18
在161篇纳入文献中，随机对照试验仅3篇，占1.9%，综述、观察性临床研究、病例系列、早期临床经验以及技术评价仍占主体。
Open source S12
结果显示，2020年以后机器人辅助血管介入研究进入快速增长阶段，并于2024年达到发文高峰，但研究数量增加并不等于临床证据成熟。
Open source S11
Source：Chinese robotics — Research news discovery · thepaper.cn